Adicet Bio Inc

NASDAQ:ACET  
19.26
+0.68 (+3.66%)
4:27:01 PM EDT: $18.78 -0.48 (-2.49%)
Earnings Announcements

Adicet Reports Third Quarter 2022 Results

Published: 11/08/2022 22:49 GMT
Adicet Bio Inc (ACET) - Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates.
$282.7 Million in Cash and Cash Equivalents As of September 30, 2022; Cash Runway Into First Half of 2025.
Qtrly Net Loss of $0.53 per Basic and Diluted Share.
Q3 Earnings per Share View $-0.53 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $12.75 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.